益肾化湿颗粒治疗肾脏病临床应用专家共识

2020-06-30 中华中医药学会中华肾病研究电子杂志.2020.9(3):97-101.

近年来随着临床应用经验的积累，益肾化湿颗粒治疗慢性肾病的疗效得到广泛认可，同时也存在较多超说明书使用的现象。为了进一步指导和规范益肾化湿颗粒在ＣＫＤ治疗中的临床应用，中华中医药学会邀请了国内中西医肾

中文标题：

益肾化湿颗粒治疗肾脏病临床应用专家共识

发布机构：

中华中医药学会

发布日期：

2020-06-30

简要介绍：

近年来随着临床应用经验的积累，益肾化湿颗粒治疗慢性肾病的疗效得到广泛认可，同时也存在较多超说明书使用的现象。为了进一步指导和规范益肾化湿颗粒在ＣＫＤ治疗中的临床应用，中华中医药学会邀请了国内中西医肾脏病临床、药理学和统计学等方面的专家，对益肾化湿颗粒的上市前后的相关研究成果进行了回顾、整理和分析。同时，结合相关专家的临床应用经验，形成《益肾化湿颗粒治疗肾脏病临床应用专家共识》，以期丰富其适应证，完善其现有应用指导方针，指导其临床合理应用。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=5ffb71c001958e70, title=益肾化湿颗粒治疗肾脏病临床应用专家共识, enTitle=, guiderFrom=中华肾病研究电子杂志.2020.9(3):97-101., authorId=0, author=, summary=近年来随着临床应用经验的积累，益肾化湿颗粒治疗慢性肾病的疗效得到广泛认可，同时也存在较多超说明书使用的现象。为了进一步指导和规范益肾化湿颗粒在ＣＫＤ治疗中的临床应用，中华中医药学会邀请了国内中西医肾, cover=https://img.medsci.cn/2020830/1598721631180_2020535.jpg, journalId=0, articlesId=null, associationId=614, associationName=中华中医药学会, associationIntro=隶属于中华中医药学会。中华中医药学会是我国成立最早、规模最大的中医药学术团体。中华中医药学会接受业务主管部门中国科学技术协会和登记管理机关民政部的业务指导与监督管理。学会办事机构是国家中医药管理局直属事业单位。中华中医药学会是全国中医药科学技术工作者和管理工作者及中医药医疗、教育、科研、预防、康复、保健、生产、经营等单位自愿结成并依法登记成立的全国性、学术性、非营利性法人社会团体，是党和政府联系中医药科学技术工作者的纽带，是中国科学技术协会的组成部分，是发展我国中医药科技事业的重要社会力量。, copyright=0, guiderPublishedTime=Tue Jun 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>近年来随着临床应用经验的积累，益肾化湿颗粒治疗慢性肾病的疗效得到广泛认可，同时也存在较多超说明书使用的现象。为了进一步指导和规范益肾化湿颗粒在ＣＫＤ治疗中的临床应用，中华中医药学会邀请了国内中西医肾脏病临床、药理学和统计学等方面的专家，对益肾化湿颗粒的上市前后的相关研究成果进行了回顾、整理和分析。同时，结合相关专家的临床应用经验，形成《益肾化湿颗粒治疗肾脏病临床应用专家共识》，以期丰富其适应证，完善其现有应用指导方针，指导其临床合理应用。</p> </div> </div> </div>, tagList=[TagDto(tagId=281, tagName=肾脏病)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=281, guiderKeyword=肾脏病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4829, appHits=175, showAppHits=0, pcHits=1389, showPcHits=4654, likes=6, shares=11, comments=7, approvalStatus=1, publishedTime=Sun Aug 30 01:28:54 CST 2020, publishedTimeString=2020-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 30 01:20:42 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 22:51:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=益肾化湿颗粒治疗肾脏病临床应用专家共识_王耀献.pdf)])

益肾化湿颗粒治疗肾脏病临床应用专家共识_王耀献.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=975482, encodeId=aa999e54821f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc75530316, createdName=ms3000001304366649, createdTime=Mon Jun 21 15:42:27 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895046, encodeId=317f895046cc, content=不错，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Wed Oct 28 12:57:22 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882521, encodeId=499f882521eb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Thu Sep 03 18:15:38 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881113, encodeId=e6fd88111338, content=学习，不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:31:51 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
2021-06-21 ms3000001304366649

好

60 0
[GetPortalCommentsPageByObjectIdResponse(id=975482, encodeId=aa999e54821f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc75530316, createdName=ms3000001304366649, createdTime=Mon Jun 21 15:42:27 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895046, encodeId=317f895046cc, content=不错，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Wed Oct 28 12:57:22 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882521, encodeId=499f882521eb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Thu Sep 03 18:15:38 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881113, encodeId=e6fd88111338, content=学习，不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:31:51 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
2020-10-28 124a6bfdm47暂无昵称

不错，学习了

96 0
[GetPortalCommentsPageByObjectIdResponse(id=975482, encodeId=aa999e54821f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc75530316, createdName=ms3000001304366649, createdTime=Mon Jun 21 15:42:27 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895046, encodeId=317f895046cc, content=不错，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Wed Oct 28 12:57:22 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882521, encodeId=499f882521eb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Thu Sep 03 18:15:38 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881113, encodeId=e6fd88111338, content=学习，不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:31:51 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
2020-09-03 ms7000000139248197

好

97 0
[GetPortalCommentsPageByObjectIdResponse(id=975482, encodeId=aa999e54821f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc75530316, createdName=ms3000001304366649, createdTime=Mon Jun 21 15:42:27 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895046, encodeId=317f895046cc, content=不错，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61022504273, createdName=124a6bfdm47暂无昵称, createdTime=Wed Oct 28 12:57:22 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882521, encodeId=499f882521eb, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Thu Sep 03 18:15:38 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881113, encodeId=e6fd88111338, content=学习，不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:31:51 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
2020-08-31 1488d5e7m58暂无昵称

学习，不错

104 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肾内科指南

益肾化湿颗粒治疗肾脏病临床应用专家共识

相关指南

拓展阅读

科室

工具

服务